Work

A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes

Year: 2014

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v124.21.4653.4653

Authors: Rami S Komrokji, Sheng Wei, Adam W Mailloux, Ling Zhang, Eric Padron, Jeffrey E. Lancet, Sara Tinsley, Lisa A Nardelli, Cynthia Benoit, Javier Pinilla-Ibarz, Pearlie K Epling-Burnette, Alan F List

Institution: Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4250008261

FWCI: 0.707

Cites:

Cited by: 7

Related to: 10